The Impingement Syndrome Market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The Impingement Syndrome Market refers to the condition of pain and tenderness in the shoulder caused by impingement or pinching of the tendons or bursa between the humerus bone and the acromion. This syndrome occurs either due to trauma to the shoulder joint by an injury or due to wearing over years by continuous overhead activities involving arm elevation or repetitive motion.

Market Overview:

Impingement syndrome refers to compression or pinching of the tendons or bursa between the acromion and humeral head during arm movements. This syndrome leads to shoulder pain and tenderness. The impingement syndrome treatments aim to reduce inflammation, manage pain and restore mobility. Some of the treatment options include medication, physiotherapy, corticosteroid injections and surgery.

Market key trends:

The growing geriatric population globally is one of the major factors driving the growth of the impingement syndrome market. As per the United Nations Population Fund data, by 2050 around 16.7% of the world's population will be over 65 years of age. With age, wear and tear of tendons and cartilage in shoulders increases the risk of developing impingement syndrome. Additionally, prevalence of sedentary lifestyles has increased the incidences of poor posture and lack of shoulder mobility leading to impingement syndrome. Furthermore, development of advanced arthroscopic techniques for impingement syndrome treatment over open surgeries is gaining popularity due to benefits like lesser complications, scars and faster recovery. This is expected to support the market growth during the forecast period.

Porter's Analysis

Threat of new entrants: The Impingement Syndrome Market Size requires high initial investments for R&D which poses a barrier for new players. Bargaining power of buyers: The presence of several treatment options gives high bargaining power to buyers to negotiate on prices. Bargaining power of suppliers: Established medical device manufacturers are the major suppliers with specialized product portfolio limiting the bargaining power of suppliers. Threat of new substitutes: Alternate non-surgical treatments provide limited threat due to invasiveness and long-term effectiveness of surgical procedures. Competitive rivalry: The market is fairly consolidated with key players differentiating based on portfolio breadth and depth intensifying competition.

SWOT Analysis

Strengths: Availability of minimally invasive surgical procedures reducing recovery time and complications. Weaknesses: High cost of surgical treatment and lack of awareness in developing regions about early diagnosis and management. Opportunities: Rising geriatric population suffering from joint disorders and growing healthcare expenditure boosting market growth. Threats: Risk of implant failure and revision surgeries; reimbursement issues related to new and costly treatments.

Key Takeaways

The global impingement syndrome market is expected to witness high growth at a CAGR of 7.5% over the forecast period due to rising number of sport injuries and growing obesity rates leading to shoulder disorders.

Regionally, North America dominates the impingement syndrome market owing to availability of advanced healthcare facilities and favorable reimbursement policies in the US and Canada. Europe holds the second largest market share with major markets being Germany, UK, and France.

Key players operating in the impingement syndrome market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., Bioventus LLC. The market is marked by new product approvals, partnerships, and mergers and acquisitions for portfolio expansion.

Read Our More Blogs : https://www.dailyprbulletin.com/impingement-syndrome-market-size-share-analysis-2023-2030/